The Wall Street Journal Health Blog published an interesting inside look of - as they put it - "how drug makers can try to lay the groundwork for sales well before a new therapy hits the market."
The topic is premature ejaculation.
Some might call the methods "disease-mongering."
Leave a comment.
Enter Comments, but.... I welcome comments but will delete those with product pitches, profanity, personal attacks or those from anyone who doesn't list what appears to be an actual e-mail address. We also don' t give medical advice and won't respond to any questions asking for it.